Literature DB >> 1680137

Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.

S A Fiscus1, E B Wallmark, J D Folds, J Fryer, C M van der Horst.   

Abstract

The detection of infectious immune complexes in plasma after human immunodeficiency virus (HIV) infection may be useful as a surrogate marker of progression of disease and may help in understanding the pathogenesis of AIDS. Polyethylene glycol (PEG) precipitates of plasma were tested for the presence of HIV p24 antigen and infectious virus. Results were compared with data from cell and plasma cultures, plasma p24 antigen, CD4 cell counts, and stage of disease. PEG precipitation increased the detection rate of the p24 antigen assay from 38.3% to 58.7%. There was a significant correlation between precipitable p24 antigen and plasma viremia, changes in CD4 cell counts, and progression of disease. The sensitivity of the PEG-precipitable p24 antigen assay versus traditional p24 antigen testing was 59.0% and the specificity 91.7%. The assay was reproducible and may be a useful determinant of viral load, clinical progression, and antiretroviral efficacy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680137     DOI: 10.1093/infdis/164.4.765

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.

Authors:  D J Witt; C C Ginocchio; X P Wang; M K Kaufman
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.

Authors:  X X Peng; M A Wainberg; Y Tao; B G Brenner
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages.

Authors:  L Z Pan; A Werner; J A Levy
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

4.  Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants.

Authors:  D E Lewis; A Adu-Oppong; F B Hollinger; H M Rosenblatt; I C Hanson; J M Reuben; M W Kline; C A Kozinetz; W T Shearer
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

5.  Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH.

Authors:  R A Pokriefka; O Manzor; N P Markowitz; L D Saravolatz; P Kvale; R M Donovan
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection.

Authors:  T Cabezas; E Quirós; F Garcia; J Hernández-Quero; M C Bernal; M A Martinez; J de la Higuera; G Piédrola; M C Maroto
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

7.  Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

Authors:  Penny L Moore; Emma T Crooks; Lauren Porter; Ping Zhu; Charmagne S Cayanan; Henry Grise; Paul Corcoran; Michael B Zwick; Michael Franti; Lynn Morris; Kenneth H Roux; Dennis R Burton; James M Binley
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.

Authors:  G Pulido-Cejudo; B Conway; P Proulx; R Brown; C A Izaguirre
Journal:  Antiviral Res       Date:  1997-12       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.